Clinical trials
Withdrawn Phase 2 trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brugmann University Hospital | 3 |
| Jules Bordet Institute | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Sangart | 2 |
| Ablynx, a Sanofi company | 1 |
| Bristol-Myers Squibb | 1 |
| CSL Behring | 1 |
| Crucell Holland BV | 1 |
| Eli Lilly and Company | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 3 |
| Acidosis, Lactic | 1 |
| Acute Kidney Injury | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Anemia, Sickle Cell | 1 |
| Brain Diseases | 1 |
| Brain Neoplasms | 1 |
| Callosities | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Central Nervous System Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.